RIBOBODY Trademark

Trademark Overview

On Friday, June 28, 2024, a trademark application was filed for RIBOBODY with the United States Patent and Trademark Office. The USPTO has given the RIBOBODY trademark a serial number of 98623781. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, September 15, 2025. This trademark is owned by Ribo Therapeutics Inc.. The RIBOBODY trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical, therapeutic pharmaceuticals, and biopharmaceutical preparations and agents for the treatment of a variety of human and animal diseases and disorders, RNA-based therapeutic pharmaceuticals and therapeutic agents for the treatment of a variety of human and animal diseases and disorders; medical diagnostic reagents and assays for testing of bodily fluids and tissue samples for the treatment and diagnosis of human and animal diseases and disorders

Chemicals for use in therapeutic product development and manufacturing processes in the medical field; Biological and chemical agents, namely, chemical preparations for scientific and research use; chemicals for use in biotherapeutics in the biochemical and chemical industries and excluding medical and veterinary purpose; biological preparations for use in industry and science; chemical agents, namely, chemical preparations for analyses in laboratories, other than for medical or veterinary purposes

Research and development of pharmaceutical, therapeutic and biopharmaceutical preparations and agents for the treatment of a variety of human and animal diseases and disorders; research and development of technology in the field of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; pharmaceutical drug development and drug discovery services; pharmaceutical research and analysis services using machine learning analytics relating to pharmaceutical drug development; scientific research, pharmaceutical research, medical research, technical consultation, and product development for others in the field of biotechnology and development of pharmaceutical, therapeutic, and biopharmaceutical preparations and agents; custom RNA targeting and assay development for the treatment of a variety of human and animal diseases and disorders in the field of biotechnology; pharmaceutical drug development related to proteins, ribosomes, DNA and RNA
ribobody

General Information

Serial Number98623781
Word MarkRIBOBODY
Filing DateFriday, June 28, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, September 15, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 7, 2025

Trademark Statements

Goods and ServicesPharmaceutical, therapeutic pharmaceuticals, and biopharmaceutical preparations and agents for the treatment of a variety of human and animal diseases and disorders, RNA-based therapeutic pharmaceuticals and therapeutic agents for the treatment of a variety of human and animal diseases and disorders; medical diagnostic reagents and assays for testing of bodily fluids and tissue samples for the treatment and diagnosis of human and animal diseases and disorders
Goods and ServicesChemicals for use in therapeutic product development and manufacturing processes in the medical field; Biological and chemical agents, namely, chemical preparations for scientific and research use; chemicals for use in biotherapeutics in the biochemical and chemical industries and excluding medical and veterinary purpose; biological preparations for use in industry and science; chemical agents, namely, chemical preparations for analyses in laboratories, other than for medical or veterinary purposes
Goods and ServicesResearch and development of pharmaceutical, therapeutic and biopharmaceutical preparations and agents for the treatment of a variety of human and animal diseases and disorders; research and development of technology in the field of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; pharmaceutical drug development and drug discovery services; pharmaceutical research and analysis services using machine learning analytics relating to pharmaceutical drug development; scientific research, pharmaceutical research, medical research, technical consultation, and product development for others in the field of biotechnology and development of pharmaceutical, therapeutic, and biopharmaceutical preparations and agents; custom RNA targeting and assay development for the treatment of a variety of human and animal diseases and disorders in the field of biotechnology; pharmaceutical drug development related to proteins, ribosomes, DNA and RNA

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, August 28, 2025
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 28, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 28, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRibo Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10036

Trademark Events

Event DateEvent Description
Friday, June 28, 2024NEW APPLICATION ENTERED
Wednesday, January 22, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 23, 2025ASSIGNED TO EXAMINER
Friday, February 28, 2025NON-FINAL ACTION WRITTEN
Wednesday, May 28, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, May 28, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, August 28, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 28, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 28, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 4, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 28, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 28, 2025NON-FINAL ACTION E-MAILED

Related Keywords

ribobody development pharmaceutical agents preparations research therapeutic disorders chemical diseases medical